Results 61 to 70 of about 1,825,467 (355)

Medical errors in primary care clinics – a cross sectional study

BMC Family Practice, 2012
Background Patient safety is vital in patient care. There is a lack of studies on medical errors in primary care settings. The aim of the study is to determine the extent of diagnostic inaccuracies and management errors in public funded primary care ...
Khoo Ee Ming, Lee Wai Khew, Sararaks Sondi, Abdul Samad Azah, Liew Su May, Cheong Ai Theng, Ibrahim Mohd Yusof, Su Sebrina HC, Mohd Hanafiah Ainul Nadziha, Maskon Kalsom, Ismail Rohana, Hamid Maimunah A   +11 more
doaj   +1 more source

A Neural Attention Model for Categorizing Patient Safety Events

, 2017
Medical errors are leading causes of death in the US and as such, prevention of these errors is paramount to promoting health care. Patient Safety Event reports are narratives describing potential adverse events to the patients and are important in ...
JL Elman, JR Clarke, L Soldaini, MA Makary, R Pascanu, S Hochreiter, Y Lecun   +6 more
core   +1 more source

MicroRNA 196a contributes to the aggressiveness of esophageal adenocarcinoma through the MYC/TERT/NFκB axis

Molecular Oncology, EarlyView.
mir‐196a promotes Esophagus Adenocarcinoma aggressiveness. On one hand, mir‐196a targets the valosin‐containing protein (VCP) mRNA, causing the accumulation of c‐MYC protein that leads to high amounts of TERT. On the other hand, mir‐196a targets the inhibitor of NFκB (NFKBIA).
Jesús García‐Castillo, Carlos M. Martínez‐Cáceres, Manuel Bernabé‐García, Vicente Munitiz, David Ruiz de Angulo, Pascual Parrilla, Ángeles Ortiz, Luisa F. Martínez de Haro, María L. Cayuela   +8 more
wiley   +1 more source

Errores médicos Medical Errors

Acta Médica Costarricense, 2009
El error médico es cualquier falla ocurrida durante la atención de salud que haya causado algún tipo de daño al paciente, y cuyo origen puede relacionarse con la organización e implementación del servicio, a través de múltiples y complejos mecanismos ...
Carlos Arrea-Baixench
doaj   +2 more sources

The anticancer effect of the HDAC inhibitor belinostat is enhanced by inhibitors of Bcl‐xL or Mcl‐1 in ovarian cancer

Molecular Oncology, EarlyView.
The pan‐HDAC inhibitor belinostat increases the expression of the pro‐apoptotic proteins Bim, Puma, and Noxa and induces apoptosis in ovarian cancer cell lines and patient‐derived tumor organoids when used at high concentrations. Moreover, inhibiting the anti‐apoptotic proteins Bcl‐xL or Mcl‐1 sensitizes these preclinical models to the cytotoxic effect
Cécilia Thomine, Sterenn Guillemot, Louis‐Bastien Weiswald, Romane Florent, Edwige Abeilard, Florence Giffard, Emilie Brotin, Mélanie Briand, Enora Dolivet, Laurent Poulain, Marie Villedieu   +10 more
wiley   +1 more source

Statistical Errors in Medical Residency Theses

Bezmiâlem Science, 2022
Objective:The aim of this study is to evaluate the theses of residency in medicine in terms of statistical errors made and thus to contribute to the production of quality scientific publications by ensuring that scientific publishers in the field of ...
Ayşegül YABACI TAK, Fatma Ezgi CAN, Fisun KASKIR KESİN, Robab AHMADIAN, İlker ERCAN   +4 more
doaj   +1 more source

Making healthcare safer by understanding, designing and buying better IT [PDF]

, 2015
When nobody or nothing notices an error, it may turn into patient harm. We show that medical devices ignore many errors, and therefore do not adequately support patient safety.
Firth-Cozens, James, Morris, Thimbleby
core   +1 more source

Circulating tumor DNA monitoring and blood tumor mutational burden in patients with metastatic solid tumors treated with atezolizumab

Molecular Oncology, EarlyView.
In patients treated with atezolizumab as a part of the MyPathway (NCT02091141) trial, pre‐treatment ctDNA tumor fraction at high levels was associated with poor outcomes (radiographic response, progression‐free survival, and overall survival) but better sensitivity for blood tumor mutational burden (bTMB).
Charles Swanton, Russell W. Madison, Candice Francheska B. Tambaoan, Funda Meric‐Bernstam, Christopher J. Sweeney, Razelle Kurzrock, Howard A. Burris III, David R. Spigel, Hanna Tukachinsky, Jason Hughes, Julia Malato, Bongin Yoo, Tania Szado, Cheryl Schwab, Lincoln W. Pasquina, Amaya Gasco, Katja Schulze, Claire F. Friedman   +17 more
wiley   +1 more source

Dose‐dependent induction of epithelial‐mesenchymal transition in 3D melanoma models by non‐thermal plasma treatment

Molecular Oncology, EarlyView.
Non‐thermal plasma treatment of melanoma cells induced epithelial‐mesenchymal transition (EMT) in a dose‐dependent fashion. This report highlights the critical need to further investigate potential adverse effects of non‐thermal plasma for cancer therapy and to optimize treatment parameters for clinical translation. Despite the promising results of non‐
Eline Biscop, Edgar Cardenas De La Hoz, Hanne Verswyvel, Joey De Backer, Ho Wa Lau, Angela Privat‐Maldonado, Wim Vanden Berghe, Steve Vanlanduit, Evelien Smits, Annemie Bogaerts, Abraham Lin   +10 more
wiley   +1 more source

Agreement between methods of retinoscopy, conventional subjective refraction and fogging subjective refraction [PDF]

Reviews in Clinical Medicine
Purpose: to compare the refractive error measurements achieved through three distinct techniques: retinoscopy, subjective method, and the subjective fogging method. Methods: Participants included 223 young adults aged 18 to 36 years (mean age: 25.63±5.31)
Atefeh Kebriaei, Asieh Ehsaei, Hadi Ostadimoghaddam, Elham Bakhtiari, Mojtaba Salamati, NEGAREH YAZDANI, Shima Mesbahi   +6 more
doaj   +1 more source